Medicines

  1. Relumina (relugolix)
    Relumina (relugolix)
    by Takeda Pharma A/S
    for
    €1,256.40
  2. Orilissa (elagolix)
    Orilissa (elagolix)
    by AbbVie Ltd
    for
    €1,050.06
  3. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
    €17,768.40
  4. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
    for
    €6,792.00
  5. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €8,382.72
  6. Kalydeco (ivacaftor)
    Kalydeco (ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €12,807.00
  7. Symkevi / Symdeko (tezacaftor/ivacaftor)
    Symkevi / Symdeko (tezacaftor/ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €7,795.80
  8. Vitrakvi (larotrectinib)
    Vitrakvi (larotrectinib)
    by Bayer
    for Solid Tumor
    €15,204.00
  9. Vizimpro (dacomitinib)
    Vizimpro (dacomitinib)
    by Pfizer Limited
    for Lung Cancer
    €18,420.00
View as Grid List

Items 1-9 of 70

Page
per page
Set Descending Direction